Latest news

• FDA issues counterfeit Adderall warning

  Legitimate versions of Adderall should contain dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate. ... Rogue websites and distributors may especially target medicines in short supply for

• Shire's once-daily ADHD drug Venvanse accepted for European review

  If approved it would become the first amphetamine-based drug to be licensed for attention deficit hyperactivity disorder (ADHD) in Europe, where Shire has been working to overcome scepticism of the ... In addition to Venvanse, Shire's ADHD portfolio

• Shire's Q3 net profit doubles

  Shire's Q3 net profit doubles. Net profit for Shire recovers from payment to Acceleron and impairment charges relating to the divestment of Daytrana. ... Products that performed particularly well in the quarter included ADHD treatments Vyvanse

• Shire ADHD scholarship programme

  Applicants' work experience, volunteer/extracurricular activities, and academic transcripts will also be taken into account. ... use as adjunctive therapy to stimulants; the extended-release drug Vyvanse (lisdexamfetamine dimesylate), which was approved

• New use cleared for Shire ADHD drug

  The company's ADHD portfolio also includes the extended-release drug VyVanse (lisdexamfetamine dimesylate), which was approved in the US in 2007, and Adderall XR (dextroamphetamine and amphetamine), which was approved ... in 2001 and has patent